Leishmaniasis, Mucocutaneous - 7 Studies Found
| Completed |
: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis : Leishmaniasis, Mucocutaneous : 2005-05-20 : Biological: Leish-111f + MPL-SE vaccine |
| Recruiting |
: Low Antimonial Dosage in American Mucosal Leishmaniasis :
|
| Completed |
: Miltefosine to Treat Mucocutaneous Leishmaniasis :
: 2010-01-12 : Drug: miltefosine 2.5 mg/kg/day for 28 days |
| Available |
: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis :
: Drug: sodium stibogluconate (Pentostam) 20 mg/kg IV every day for 20 or 28 days |
| Completed |
: Miltefosine for Mucosal Leishmaniasis : Leishmaniasis : 2006-09-07 : Drug: miltefosine 2.5 mg/kg/day for 28 days |
| Completed |
: Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis : Leishmaniasis : 2006-09-07 : Drug: miltefosine: 2.5 mg/kg/day for 42 days |
| Not yet recruiting |
: Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia :
|